Weng, C.-W.; Wei, C.-H.; Tsai, J.-Y.; Lai, Y.-H.; Chang, G.-C.; Chen, J.J.W.
Hybrid Pharmacophore- and Structure-Based Virtual Screening Pipeline to Identify Novel EGFR Inhibitors That Suppress Non-Small Cell Lung Cancer Cell Growth. Int. J. Mol. Sci. 2022, 23, 3487.
https://doi.org/10.3390/ijms23073487
AMA Style
Weng C-W, Wei C-H, Tsai J-Y, Lai Y-H, Chang G-C, Chen JJW.
Hybrid Pharmacophore- and Structure-Based Virtual Screening Pipeline to Identify Novel EGFR Inhibitors That Suppress Non-Small Cell Lung Cancer Cell Growth. International Journal of Molecular Sciences. 2022; 23(7):3487.
https://doi.org/10.3390/ijms23073487
Chicago/Turabian Style
Weng, Chia-Wei, Chi-Hsuan Wei, Jeng-Yuan Tsai, Yi-Hua Lai, Gee-Chen Chang, and Jeremy J. W. Chen.
2022. "Hybrid Pharmacophore- and Structure-Based Virtual Screening Pipeline to Identify Novel EGFR Inhibitors That Suppress Non-Small Cell Lung Cancer Cell Growth" International Journal of Molecular Sciences 23, no. 7: 3487.
https://doi.org/10.3390/ijms23073487
APA Style
Weng, C.-W., Wei, C.-H., Tsai, J.-Y., Lai, Y.-H., Chang, G.-C., & Chen, J. J. W.
(2022). Hybrid Pharmacophore- and Structure-Based Virtual Screening Pipeline to Identify Novel EGFR Inhibitors That Suppress Non-Small Cell Lung Cancer Cell Growth. International Journal of Molecular Sciences, 23(7), 3487.
https://doi.org/10.3390/ijms23073487